Serum MMP-3 in rheumatoid arthritis: correlation with systemic inflammation but not with erosive status

A So1, A M Chamot, V Péclat

  • 1Rheumatology Service, University Hospital of Lausanne, Switzerland.

Abstract

Insights

Serum matrix metalloproteinase-3 (MMP-3) levels do not independently predict joint damage in rheumatoid arthritis (RA). However, MMP-3 levels correlate with systemic inflammation markers in RA patients.

Area of Science:

  • Biochemistry
  • Rheumatology
  • Immunology

Background:

  • Matrix metalloproteinases (MMPs) are crucial for extracellular matrix remodeling.
  • Their role in pathological tissue damage, particularly in rheumatoid arthritis (RA), requires further clarification.
  • Stromelysin (MMP-3) is upregulated in RA and has been investigated as a potential marker for joint damage.

Purpose of the Study:

  • To investigate the relationship between serum MMP-3 levels and joint erosions in patients with active RA.
  • To determine if serum MMP-3 is an independent predictor of radiographic joint damage in RA.

Main Methods:

  • Fifty-three patients with active RA (disease duration > 5 years) were included.
  • Hand X-rays were assessed for erosions and patients stratified into high and low erosion groups.
  • Serum MMP-3 levels were compared between these patient groups.

Main Results:

  • No significant difference in serum MMP-3 levels was observed between patients with high and low levels of joint erosion.
  • A statistically significant correlation was found between serum MMP-3 levels and erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP).

Conclusions:

  • Serum MMP-3 is not an independent marker for joint damage in RA.
  • Serum MMP-3 levels are associated with systemic inflammation in RA.
  • The specific role of MMP-3 in RA-related joint damage warrants further investigation.